Home > Boards > US Listed > Medical - Healthcare > Second Sight Medical Products Inc (EYES)

Second Sight Announces Departure of Will McGuire, President

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Big Barnie Member Profile
 
Followed By 2
Posts 893
Boards Moderated 1
Alias Born 07/11/13
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 1:09:20 PM
UiPath, Campbell among premarket losers' pack Seeking Alpha - 6/9/2021 8:25:44 AM
Second Sight Medical files for $250 million mixed securities shelf offering Seeking Alpha - 6/9/2021 6:55:08 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/8/2021 5:01:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2021 6:04:01 AM
Second Sight Medical Products Announces Results of its 2021 Annual Meeting Business Wire - 6/1/2021 6:00:00 AM
Second Sight Medical trades higher on news of patent win Seeking Alpha - 5/21/2021 12:16:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2021 6:03:48 AM
Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study Business Wire - 5/13/2021 6:00:00 AM
Second Sight Medical reports two-year results of its Orion study Seeking Alpha - 5/12/2021 6:25:26 AM
Second Sight Medical Products Announces Two-Year Results of its Orion Study Business Wire - 5/12/2021 6:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2021 5:25:08 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/29/2021 6:16:20 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/27/2021 5:40:31 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/27/2021 4:10:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/22/2021 4:42:52 PM
Second Sight slips 8% on launch of stock offering Seeking Alpha - 4/16/2021 8:34:12 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/16/2021 6:02:07 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/7/2021 6:02:22 AM
Second Sight Medical Products Names Dean Baker and Alexandra Larson to its Board of Directors Business Wire - 4/6/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2021 6:29:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 9:19:25 AM
Second Sight Medical terminates business combination with Pixium Vision Seeking Alpha - 4/3/2021 9:13:41 PM
Second Sight Medical appoints new acting CEO Seeking Alpha - 4/1/2021 1:29:12 PM
Second Sight Medical Products Names Scott Dunbar Acting CEO Business Wire - 4/1/2021 8:00:00 AM
Big Barnie   Friday, 03/13/20 09:53:13 AM
Re: None
Post # of 1174 
Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEO

LOS ANGELES--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the departure of Will McGuire, President and Chief Executive Officer (“CEO”), effective March 27, 2020, to pursue another professional opportunity located closer to his family. Mr. McGuire remains as a director on Second Sight’s board.

Effective March 27, 2020, Gregg Williams, the Company’s Chairman of the Board, will assume the role of Acting CEO. Reporting to Mr. Williams will be John T. Blake, Chief Financial Officer and Pat Ryan, Chief Operating Officer. The Board is initiating a search process in order to identify the future CEO.

“I have tremendous confidence in John’s and Pat’s abilities and I look forward to working together with them to lead the Second Sight team into this exciting new phase of our journey,” stated Gregg Williams.

“I would like to take this opportunity to thank Will for his many contributions to Second Sight over the past four and a half years as President and CEO, during which time he led the implementation of our strategy to focus on the development and advancement of our breakthrough Orion® Visual Cortical Prosthesis System. I also look forward to his continued contributions as a board member. I believe that the 12-month results from the Orion Early Feasibility Study are extremely encouraging, and we continue to make great progress advancing this life-changing neuro-modulation technology, not only in pursuit of our quest to treat all forms of blindness, but eventually in many other fields using derivatives of the same basic core technologies and software,” continued Mr. Williams.

“It has been my honor to lead the incredibly talented team at Second Sight,” said Will McGuire. “I am extremely proud of the accomplishments we have achieved in the successful advancement of Second Sight’s breakthrough neuro-modulation technology, which has the potential to provide useful artificial vision to virtually all profoundly blind individuals. I remain excited for the opportunity to continue supporting the team in my role as a board member.”


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences